• General Surgery
  • Surgical oncology

Areas of interest


Associate Professor David Gyorki is a specialist surgeon in complex surgical oncology - surgery for patients with cancer. In addition to his private practice, David is a consultant surgeon at the Peter MacCallum Cancer Centre, as well as the Olivia Newton-John Cancer Centre, with a particular interest in the management of patients with melanoma, soft tissue sarcoma and breast cancer. David is one of only a small number of surgeons in Australia with a surgical practice dedicated to the management of cancer patients. This focus allows David to understand the complexity and nuance of each individual patient and to help tailor a multidisciplinary treatment plan. By understanding the role of all treatment options in the management of his patients, he is better able to determine the best surgical approach. Sometimes optimal treatment may involve no surgery at all. After completing his training in General Surgery at St Vincent's Hospital and at the Peter MacCallum Cancer Centre, David was awarded fellowship of the Royal Australasian College of Surgeons. Following this, he pursued further specialist training in Surgical Oncology at Memorial Sloan Kettering Cancer Centre in New York, USA; one of the world's foremost cancer centres.

Consulting locations

Consulting Location

Cancer Specialists

Level 1
84 Bridge Road
Richmond VIC 3121

Consulting Location

Cancer Specialists

Level 1
766 Elizabeth Street
Melbourne VIC 3000

Epworth locations


Epworth Richmond


Epworth Freemasons Albert Street


  • MBBS
  • Postgrad Dip Surg Anat
  • MD (by research)

Education and training

  • Research and Education Lead, Skin and Melanoma, Victorian Comprehensive Cancer Centre
  • Training Supervisor for clinical fellow in melanoma and sarcoma, Peter MacCallum Cancer Centre


  • Role of surgery in patients with metastatic melanoma
  • Chair of international governance committee and Australian lead of a multisite registry for retroperitoneal sarcoma
  • Principal Investigator in randomised trial of preoperative chemotherapy for patients with retroperitoneal sarcoma at high risk of recurrence
  • Principal investigator of the Melanoma Margins Trial
  • Understanding the dormant danger of melanoma micrometastases

Professional Associations

  • Society of Surgical Oncology
  • RACS
  • Australia and New Zealand Melanoma Trials Group
  • Australia New Zealand Sarcoma Association - Board Director
  • Connective Tissue Oncology Society

Public Appointments

  • Peter MacCallum Cancer Centre

We use cookies to provide you with a customised experience which may include marketing purposes. More details can be found at our Privacy Policy.